Promoter holding
64.27%
UL
Unichem Laboratories Limited - Due diligence report
A 360° intelligence report on Unichem Laboratories: trust score, financial health, credit view, compliance, directors, growth and distress s…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Unichem Laboratories — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Unichem Laboratories is assessed as Low Risk with a Trust Score of 85/100. Unichem Laboratories is an active public limited indian non-government company incorporated in 1962, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 24 Jul 2026 from the latest processed filings. Unichem Laboratories Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
72/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 4 open (236.00 cr) · 50 satisfied (249.07 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 2 | 48.0 cr |
| Bank Of India | 17 | 48.0 cr |
| Citi Bank N.A. | 3 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
| Icici Limited | 1 | 48.0 cr |
| Cooperative Centrale Raiffeisen Boerenle Enbank B.A. | 1 | 48.0 cr |
Compliance Score: 72/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 5 court forum(s).
- Delayed payments to MSME suppliers disclosed (5 disclosure(s)).
- 6 active GST registration(s).
Legal cases on record (5)
05
Director Intelligence
Stability score: 75/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PRANAY PREMCHAND GODHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PABITRAKUMAR KALIPADA BHATTACHARYYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAKASH AMRUT MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARUN TODARWAL LALCHAND | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRITI PURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANAND TRIMBAK KUSRE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY BHAWARLAL JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pradeep Bhandari | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Swati Arvind Patankar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 9 directors on the board.
- No disqualified or deactivated DINs.
- 7 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
60 allotment(s) · 0 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Synchron Research Services Private Limited | Associate Company | 74.00% |
Key managerial personnel: PABITRAKUMAR KALIPADA BHATTACHARYYA (Managing Director) · SANJAY BHAWARLAL JAIN (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 63+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
4 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 78,140.00.
5 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 4 open charge(s) of 236.00 cr already registered.
- Compliance record supports lending.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events05 Feb 2026
Director appointed
Swati Arvind Patankar (Additional Director)
04 Aug 2025
Last AGM held
Annual general meeting
17 Jul 2025
Charge satisfied
Axis Bank Limited
20 Jun 2025
Charge created
Citi Bank N.A. - 30.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
24 Jan 2025
Charge created
Citi Bank N.A. - 51.00 cr
13 Aug 2024
Director appointed
SANJAY BHAWARLAL JAIN (CFO)
07 Aug 2024
Charge satisfied
Bank Of India
19 Jun 2024
Charge satisfied
Citi Bank N.A.
31 Mar 2024
Director ceased
PRAFULBHAI ANUBHAI SHAH
Director ceased
ANAND YASHAVANT MAHAJAN
Director ceased
PRAFULL D SHETH
21 Mar 2024
Director ceased
ARUN TODARWAL LALCHAND
Director ceased
ANAND TRIMBAK KUSRE
05 Feb 2024
Director appointed
ARUN TODARWAL LALCHAND (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
9 active director(s) / partner(s); board looks stable and experienced.
6 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 60 security allotment(s) - amounts available in the full report.
80 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Gufic Biosciences | L24100MH1984PLC033519 | Mumbai, Maharashtra, India |
| Sulphurmills | U24110MH1960PLC011752 | Mumbai, Maharashtra, India |
| Romsons | U24236UP1977PTC004511 | Uttar Pradesh, Uttar Pradesh, India |
| Indoco Remedies | L85190MH1947PLC005913 | Mumbai, Maharashtra, India |
| Madhu Silica | U24299GJ1987PTC010073 | Bhavangar, Gujarat, India |
| Willowood Chemicals Limited | U24231WB1989PLC236953 | Kolkata, West Bengal, India |
| Fdcindia | L24239MH1940PLC003176 | Mumbai, Maharashtra, India |
| Granulesindia | L24110TG1991PLC012471 | Serilingampally, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Unichem Laboratories before audits and certifications: compliance score 72/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Unichem Laboratories: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Unichem Laboratories - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Unichem Laboratories pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (5 case(s) on record), regulatory flags, charge documents trail and director networks for Unichem Laboratories - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Unichem Laboratories an active company?
Unichem Laboratories has MCA status “Active” with a compliance score of 72/100 (Moderate).
Is Unichem Laboratories financially healthy?
Unichem Laboratories has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Unichem Laboratories?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Unichem Laboratories?
Promoters hold a majority stake - exact percentages are in the full report. 9 active director(s) are on record.
Does Unichem Laboratories have loans or charges against its assets?
4 open charge(s) are registered against its assets, and 50 earlier charge(s) stand satisfied.
Is Unichem Laboratories up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 72/100 (Moderate).
Is it risky to lend to Unichem Laboratories?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
